u u u u
OF PULMONARY FUNCTION TESTING
u u u u
11 TH EDITION BYMOTTRAM BRAND
u u u u u
NEW2024/2025.
,Chapter s1: s Indications s for sPulmonary s Function sTesting
sTestsBank
MULTIPLE s CHOICE
1. Who s first s popularized s spirometry s for s the s evaluation s of s pulmonary s function?
a. August s and s Marie s Krogh
b. Alvan s Barach
c. John s Severinghaus
d. John s Hutchinson
ANS: s D
Hutchinson s popularized s the s concept s of s using s VC s to s assess s lung s function,
s and s the snames s hegave s to s several s other s lung s compartments suare s still s used
sutoday.
DIF: 1 REF: p. s 2 OBJ: None MSC: s NBRC: suNone
2. Which s of s the s following s are s indications s for superforming s spirometry?
1. Assess s the s risk s of s lung s resection.
2. Determine s the s response s to subronchodilator s therapy.
3. Assess s the s severity s of s restrictive sulung s disease.
4. Quantify s the s extent suof s COPD.
a. 1 and 4
b. 2 and 3
c. 1 s , s 2, s and su s 4
d. 2 s , s 3, suand su su4
ANS: suC
Spirometry s cannot suassess s severity s of s restriction; s for s that s you s need s to s measure
s lung
uvolumes s (usee s Box su1-2, s Chapter 1).
DIF: 1 REF: p. s 7 OBJ: EL-2 MSC: s NBRC: s None
,3. The s main s indication s for s the s measurement s of s lung s volumes s is s to s do
s which s of s the sfollowing?
a. Diagnose s or s assess s the s severity s of s restriction.
b. Evaluate s the s severity s of s pulmonary s hypertension.
c. Determine s the s level s of s cardiopulmonary s fitness.
d. Assess s the s risk s of s abdominal s surgical s procedures.
ANS: s A
The s most s common s reason s for s measuring s lung s volumes s is s to s identify
s restrictive s lung sdisease. sDIF: 1 REF: p. s 35 s OBJ: EL-2 MSC:
s NBRC: s None
4. DLCO s measurements s may s be s indicated s to s evaluate s pulmonary in s which
suinvolvement sof s thefollowing s systemic s diseases?
a. Asthma
b. Sarcoidosis
c. Exertional s hypoxemia
, Stuvia.com s - s The s Marketplace s to s Buy
s and s Sell s your
d. s s Guillain-Barré s syndrome
ANS: s B
Sarcoidosis s is s the s only s systemic s disease s listed s that
s affects s gas sexchange. sDIF: s 1 s REF: s p. s 9 s | s p. s 19 s | s p.
s 21 s | s p. s 35 s OBJ: s EL-2 sMSC: s NBRC: s None
5. Blood s gas s analysis s is s used s with s patients s with s COPD
s to s do swhich s of s thefollowing?
a. Monitor s airway s responsiveness.
b. Determine s level s of s cardiopulmonary s fitness.
c. Detect s pulmonary s hypertension.
d. Assess s need s for s supplementary s O2.
ANS: s D
Blood s gas s analysis s is s most s commonly s used s to s determine s the s need s for
s supplemental soxygenand s to s manage s patients s who s require s ventilatory s support.
DIF: 2 REF: p. s 15 s OBJ: EL-1
sMSC: s NBRC: s CPFT s 2A-2
6. Which s of s the s following s cause s emphysema?
1. 1- s Antitrypsin s deficiency
2. Exposure s to s environmental s pollutants
3. Radiation s therapy
4. Cigarette s smoking
a. 1 and 2
b. 3 and 4
c. 1 s , s 2, s and 4
d. 2 s , s 3, s and 4
ANS: s C
Emphysema sis scaused sprimarily sby scigarette ssmoking. sSome semphysema sis scaused sby
stheabsence s of s a s protective s enzyme. s Chronic s exposure s to s environmental
s pollutants s can salso s contribute s to s the s development s of s emphysema.
DIF: 1 REF: p. s 11 s s OBJ: EL-3 s | s AL-2 s MSC: s NBRC: s None
7. An s adult s patient s complains s of s chest s tightness s and s cough s whenever s he
s jogs s in s cold sweather. sThese s symptoms s are s consistent s with s which s of s the
s following?
a. Cystic s fibrosis
b. Asthma
c. Pulmonary s hypertension
d. Idiopathic s pulmonary s fibrosis